https://acvecc.digitellinc.com/p/cf/american-college-of-veterinary-emergency-and-critical-care-post-graduate-review-7
https://acvecc.digitellinc.com/p/s/the-vetcot-trauma-registry-a-literature-review-10
https://acvecc.digitellinc.com/p/s/academic-health-care-partnerships-lessons-learned-on-rapidly-pivoting-during-a-pandemic-15
https://acvecc.digitellinc.com/p/s/break-20
https://acvecc.digitellinc.com/p/s/the-endothelium-in-trauma-25
https://acvecc.digitellinc.com/p/s/the-omics-of-trauma-30
https://acvecc.digitellinc.com/p/s/lunch-with-nva-35
https://acvecc.digitellinc.com/p/s/traumatic-brain-injury-translational-potential-40
https://acvecc.digitellinc.com/p/s/trauma-wound-management-45
https://acvecc.digitellinc.com/p/s/break-50
https://acvecc.digitellinc.com/p/s/end-points-of-resuscitation-in-trauma-patients-55
https://acvecc.digitellinc.com/p/s/military-trauma-60
https://acvecc.digitellinc.com/p/s/coagulopathic-implication-of-trauma-and-hypofibrinolysis-65
https://acvecc.digitellinc.com/p/s/viscoelastic-testing-in-trauma-devicesuses-70
https://acvecc.digitellinc.com/p/s/break-75
https://acvecc.digitellinc.com/p/s/whole-blood-vs-component-therapy-in-trauma-80
https://acvecc.digitellinc.com/p/s/platelet-transfusions-in-trauma-indications-and-evidence-85
https://acvecc.digitellinc.com/p/s/autologous-blood-transfusion-in-trauma-90
https://acvecc.digitellinc.com/p/s/lunch-with-bluepearl-95
https://acvecc.digitellinc.com/p/s/teg-guided-transfusions-whats-the-evidence-100
https://acvecc.digitellinc.com/p/s/fibrinolysis-recent-studies-and-antifibrinolytics-105
https://acvecc.digitellinc.com/p/s/damage-control-and-massive-transfusions-110
https://acvecc.digitellinc.com/p/s/break-115
https://acvecc.digitellinc.com/p/s/plasma-are-we-treating-the-endothelium-120
https://acvecc.digitellinc.com/p/s/cases-in-perioperative-bleeding-125
https://acvecc.digitellinc.com/p/s/future-directions-of-therapy-130
https://acvecc.digitellinc.com/p/s/overall-event-evaluation-132
https://acvecc.digitellinc.com/p/cf/pgr-2023-165
https://acvecc.digitellinc.com/p/s/principles-and-indications-for-renal-replacement-therapy-166
https://acvecc.digitellinc.com/p/s/renal-replacement-therapy-dialyzers-dialysate-adequacy-and-outcome-167
https://acvecc.digitellinc.com/p/s/break-168
https://acvecc.digitellinc.com/p/s/writing-prescriptions-for-renal-replacement-therapy-169
https://acvecc.digitellinc.com/p/s/anticoagulation-170
https://acvecc.digitellinc.com/p/s/lunch-break-171
https://acvecc.digitellinc.com/p/s/vascular-access-172
https://acvecc.digitellinc.com/p/s/hemoperfusion-173
https://acvecc.digitellinc.com/p/s/break-174
https://acvecc.digitellinc.com/p/s/therapeutic-plasma-exchange-175
https://acvecc.digitellinc.com/p/s/complications-176
https://acvecc.digitellinc.com/p/s/diabetic-ketoacidosis-and-hyperglycemic-hyperosmolar-syndrome-177
https://acvecc.digitellinc.com/p/s/diabetic-ketoacidosis-and-hyperglycemic-hyperosmolar-syndrome-continued-insulin-therapy-178
https://acvecc.digitellinc.com/p/s/break-179
https://acvecc.digitellinc.com/p/s/insulin-therapy-continued-180
https://acvecc.digitellinc.com/p/s/addisons-disease-181
https://acvecc.digitellinc.com/p/s/lunch-break-182
https://acvecc.digitellinc.com/p/s/glucose-metabolism-183
https://acvecc.digitellinc.com/p/s/insulinoma-184
https://acvecc.digitellinc.com/p/s/break-185
https://acvecc.digitellinc.com/p/s/circi-186
https://acvecc.digitellinc.com/p/s/hyperparathyroidism-187
https://acvecc.digitellinc.com/p/s/overall-evaluation-190